Skip to main content

GOLDMAN SACHS GROUP INC

Position in ADCT — ADC Therapeutics SA

CIK 886982 NEW YORK, NY

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,198,847
+$406,570 QoQ
Shares Held
1,653,026
+0.7% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. ADCT ranks #32 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,198,847 1,653,026
2025-12-31 $5,792,277 1,640,872
2025-09-30 $6,377,736 1,594,434
2025-06-30 $4,134,173 1,542,602
2025-03-31 $2,232,187 1,583,112
2024-12-31 $3,329,621 1,673,177
2024-09-30 $5,319,070 1,688,594
2024-06-30 $4,818,105 1,524,717
2024-03-31 $6,916,885 1,540,509
2023-12-31 $2,422,793 1,459,514
2023-09-30 $944,521 1,052,978
2023-06-30 $2,445,816 1,137,589
2023-03-31 $4,589,724 2,353,705
2022-12-31 $8,299,607 2,161,356
2022-09-30 $138,117 28,655